| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 31 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 10.08.2018 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singapore/GP1908/2015) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Singapore/INFIMH-16-0019/2016 (H3N2)-like: reassortant virus NIB-104) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant virus B/Maryland/15/2016 NYMC BX-69A (Victoria lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/michigan/45/2015 (H1N1)-Like: Reassortant Virus Ivr-180 Derived from A/singapore/gp1908/2015) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/singapore/infimh-16-0019/2016 (H3N2)-Like: Reassortant Virus Nib-104) | 15 µg | | Haemagglutininum Influenzae b (Virus Stamm B/colorado/06/2017-Like: Reassortant Virus B/maryland/15/2016 nymc Bx-69A (Victoria Lineage)) | 15 µg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Chloride | | | | Cetrimide | | | | Disodium Phosphate Dihydrate | | | | Formaldehydum | | | | Gentamicinum Nihil | | | | Potassium Chloride | | | | Potassium Dihydrogenophosphate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chloride | | | | Ovalbuminum | 0.1 µg | residui | | Polysorbatum 80 | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
